<p>Prevalence of DLL3, CTLA-4 and MSTN Expression in Patients with Small Cell Lung Cancer</p>

Abstract

The expression of DLL3, CTLA-4 and MSTN was not correlated with patients' age, sex, smoking status, stage, and tumor metastasis. The fact that there was a higher expression of DLL3, CTLA-4, and MSTN in SCLC suggested that these molecules could be used as predictive biomarkers for SCLC.